The price of Abbott Laboratories (ABT) on October 9, 2026 is 99.60 USD, +1.13% on the day. Over 52 weeks the stock traded between 81.97 USD and 135.13 USD; the price now sits 33% of the way up that range. Over the past year the price changed by -25.82%. The P/E ratio is 31.3, which is above the sector median (24.8). Market capitalization is 196.52 billion USD, rank 5 among 374 stocks of the same industry with a known capitalization.
Closing prices for 09 October 2026
Next earnings report: 21 October 2026 · Earnings calendar
Abbott Laboratories trades on NYSE under the ticker ABT. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks ABT has traded between 81.97 $ and 135.13 $. As of 09 October 2026 the price stood 33.16 % of the way from the 52-week low to the high.
Over one year ABT shares fell 25.82 %; over six months they fell 0.70 %. Volatility over 90 days is 29.73 %. Dividends are not included: this is price change only, as of 09 October 2026.
ABT trades at a price-to-earnings ratio of 31.3, above the sector median of 24.8. Price to sales is 4.4, above the sector median of 3.9. Price to book is 3.8, above the sector median of 2.4. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 98.41 | 100.36 | 98.20 | 99.60 | 7M |
| 08 October 2026 | 98.56 | 99.20 | 97.20 | 98.49 | 14M |
| 07 October 2026 | 98.89 | 99.37 | 97.62 | 98.73 | 9M |
| 06 October 2026 | 100.56 | 100.95 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Abbott makes medical devices and diagnostics, best known for continuous glucose monitoring systems.
The company has four parts: medical devices, diagnostics, pharmaceuticals for emerging markets, and nutrition. That mix leaves it less exposed to a single cycle than a pure device maker or a pure drug company.
The flagship product of recent years is continuous glucose monitoring: sensors sell on subscription logic, since each is consumed and replaced regularly, and the user base grows with the prevalence of diabetes. That gives the company rising recurring revenue.
Diagnostics demonstrated the other side of cyclicality: the pandemic surge in testing ended, and year-on-year comparisons looked weak for a long time for reasons unrelated to the core business. Abbott is a dividend aristocrat with a long record of increases.
Address:100 ABBOTT PARK ROAD, ABBOTT PARK, IL, 60064-3500, US
Abbott Laboratories reported revenue of 45.1B $ and net income of 6.3B $ over the last four quarters. Net margin is 13.91 %. Revenue changed by +6.59 % year over year. Earnings per share are 3.57 $. Market capitalisation is 196.5B $.
ABT has a return on equity of 12.06 %, above the sector median of −41.68 %. Return on assets is 5.68 %, above the sector median of −32.11 %. Operating margin is 17.07 %, above the sector median of −26.84 %.
| 1.2B |
| PFEPfizer, Inc. | 28.18 | +1.28 % | 929M |
| BMYBristol-Myers Squibb Company | 59.12 | −0.77 % | 714M |
| REGNRegeneron Pharmaceuticals, Inc. | 746.54 | +0.94 % | 555M |
| NVONovo Nordisk A/S | 38.58 | +1.03 % | 545M |
| 97.94 |
| 98.16 |
| 11M |
| 05 October 2026 | 97.84 | 100.70 | 97.39 | 100.10 | 12M |
| 02 October 2026 | 97.25 | 97.59 | 95.06 | 97.50 | 9M |
| 01 October 2026 | 99.10 | 99.45 | 96.54 | 96.69 | 9M |
| 30 September 2026 | 100.57 | 100.63 | 98.72 | 98.83 | 8M |
| 29 September 2026 | 100.26 | 101.07 | 99.48 | 100.95 | 8M |
| 28 September 2026 | 101.08 | 101.76 | 100.26 | 100.98 | 7M |
| 25 September 2026 | 100.81 | 101.82 | 100.09 | 101.29 | 8M |
| 24 September 2026 | 103.77 | 104.22 | 101.02 | 101.07 | 6M |
| 23 September 2026 | 104.22 | 104.31 | 102.66 | 103.49 | 12M |
| 22 September 2026 | 104.01 | 104.54 | 102.90 | 103.69 | 8M |
| 21 September 2026 | 102.27 | 103.20 | 101.84 | 102.98 | 5M |
| 18 September 2026 | 101.83 | 103.19 | 101.50 | 102.61 | 27M |
| 17 September 2026 | 102.15 | 103.00 | 100.33 | 102.23 | 8M |
| 16 September 2026 | 101.89 | 103.30 | 101.50 | 102.36 | 5M |
| 15 September 2026 | 102.98 | 103.06 | 101.47 | 102.03 | 7M |
| 14 September 2026 | 103.56 | 104.44 | 102.57 | 103.09 | 8M |